|
UPA Chairperson Felicitates India’s First Successful Liver Transplant …
PR Newswire India (press release) UPA Chairperson and Congress Party President, Smt. Sonia Gandhi today felicitated India’s first successful liver transplant recipient, Sanjay Kandasamy from Kancheepuram, Tamil Nadu who had undergone a liver transplant in November 1998 at Apollo … |
Engineers synthesize antibodies with carbon nanotubes – Phys.Org
|
Engineers synthesize antibodies with carbon nanotubes
Phys.Org To create these “synthetic antibodies,” the researchers used carbon nanotubes—hollow, nanometer-thick cylinders made of carbon that naturally fluoresce when exposed to laser light. In the past, researchers have exploited this phenomenon to create … |
US group opposes Gilead's patenting of hepatitis C drug in India – domain-B
Hindu Business Line |
US group opposes Gilead’s patenting of hepatitis C drug in India
domain-B US drug-maker Gilead Sciences’ patent application on hepatitis C drug sofosbuvir in India is facing opposition from a US legal group I-MAK (Initiative for Medicines, Access & Knowledge) on the ground that it is old known compound and has nothing new to … US group seeks to block Gilead drug patent in IndiaEconomic Times US group against Gilead’s patent request in India for hepatitis C drugTopNews United States Indian health activists move to prevent Gilead’s drug patentFinancial Times |
Support from InvestNI Allows Fusion Antibodies to Develop New Technologies – HispanicBusiness.com
|
Support from InvestNI Allows Fusion Antibodies to Develop New Technologies
HispanicBusiness.com Fusion Antibodies, a spin out from Queen’s University, Belfast , is currently employing 10 people in its labs at Springbank Industrial Estate , near Lisburn . It is using Invest NI R&D support to develop technology services to further the work of … |
Support from InvestNI Allows Fusion Antibodies to Develop New Technologies – PR Web (press release)
PR Web (press release)Support from InvestNI Allows Fusion Antibodies to Develop New TechnologiesPR Web (press release)Support from InvestNI Allows Fusion Antibodies to Develop New Technologies. Fusion Antibodies Ltd is helping to turn leading-edge rese…
Faith Briefs – Winnipeg Free Press
|
Faith Briefs
Winnipeg Free Press Donation. Hymn Festival / Organ Celebration Messiah Lutheran Church, 400 Rouge Rd., Nov. 27, 7 p.m. This is a celebration of the 40th anniversary of Messiah’s pipe organ (A single manual Karl Wilhelm organ of seven stops with a German baroque sound). |
Apple shares interesting iPad stories on webpage – Times of India
Apple shares interesting iPad stories on webpageTimes of IndiaAccording to Mashable, these include the work of an engineer on a Siemens wind turbine, the preparations of speedskater Bridie Farrell, data analysis at Palmaz Vineyards in Napa, California,…
Single Cell Technology, ABB to develop new therapeutic antibodies – Pharmaceutical Business Review
Single Cell Technology, ABB to develop new therapeutic antibodiesPharmaceutical Business ReviewUnder the deal, SCT will use its patented platform to screen plasma cells, measure the kinetics of secreted antibodies and sequence the cognate light and hea…
Avedro Announces FDA Priority Review Status for Corneal Cross-linking New … – Fort Mills Times
|
Avedro Announces FDA Priority Review Status for Corneal Cross-linking New …
Fort Mills Times Patients with these sight threatening conditions may require corneal transplant surgery. If approved, riboflavin ophthalmic solution/KXL system would be the first FDA approved therapeutic treatment for these orphan indications. “US ophthalmic surgeons … |
Dramatic rise in chemo spending – Oncology Update
|
Dramatic rise in chemo spending
Oncology Update Just six medicines made up 58% of all chemotherapy costs in 2011: new medications rituximab, imatinib, bevacizumab and trastuzumab, and the older, generic medications docetaxel and paclitaxel. Dr Vitry said it “very surprising” to discover that such a … |